Background Endovascular therapy (EVT) is standard treatment for large vessel occlusion in patients with a National Institutes ...

XCath, a medical device company advancing neuro-endovascular surgical robotics, announced today the successful completion of ...

The DIRECT ANGIO randomised clinical trial by Benjamin Gory and colleagues1 in The Lancet Neurology was designed to test a biologically compelling premise: that a direct transfer to angiography suite ...

The noninferiority trial of patients at risk for both bleeding and stroke, in a surprise turn, found standard care to be superior.

Please provide your email address to receive an email when new articles are posted on . The Open-Motion device will undergo a future validation study to further determine its viability. Large vessel ...

XCath today announced the completion of the first telerobotic stroke case using its Iris surgical robotic system.

HELSINKI — In patients with large vessel occlusion stroke treated within 4.5 hours of symptom onset, outcomes were better in those who received the thrombolytic tenecteplase prior to endovascular ...

Please provide your email address to receive an email when new articles are posted on . During endovascular therapy for large vessel occlusion stroke, more than three attempts at clot retrieval was ...

Millions of people have a heart rhythm disorder called atrial fibrillation, which causes the heart’s upper chambers or atria ...

Recent developments of interest in cardiovascular medicine ...